NS Pharma Revenue and Competitors

Claim your profile

Paramus, NJ USA



Total Funding



Estimated Revenue & Valuation

  • NS Pharma's estimated annual revenue is currently $22.7M per year.(i)
  • NS Pharma's estimated revenue per employee is $201,000

Employee Data

  • NS Pharma has 113 Employees.(i)
  • NS Pharma grew their employee count by 14% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

NS Pharma, Inc. (NSP) located in Paramus New Jersey is a subsidiary of Nippon Shinyaku Co., Ltd. Founded in 1999 in the United States, NSP is engaged in clinical studies and partnering with global pharmaceutical companies, venture companies and research institutes. NSP serves as a contact point for connecting Japan/Asia and the world, developing drug candidates invented in Japan and out-license them to the world. From the world to Japan/Asia, NSP in-license promising drug candidates to the Japanese/Asian Markets. In coordination with parent company, Nippon Shinyaku, Co., Ltd., NSP will first and foremost develop and supply safe and highly effective pharmaceuticals through clinical studies. NSP aims to be an indispensable entity in the healthcare industry in line with the guidelines for action “Challenge”, “Speed”, and “Investigation”.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





NS Pharma News

2022-04-17 - Sarepta DMD rival PepGen files $115m IPO -

... the target of Sarepta's $90 million product Vyondys 53 (golodirsen) and privately-held NS Pharma's Viltepso (viltolarsen).

2022-04-06 - Latest Update PLI Scheme: Pharmaceutical Sector Starts ...

... PLI scheme for the pharmaceutical sector and 55 companies, including Sun Pharmaceutical Industries Ltd (NS: SUN ), Aurobindo Pharma (NS:...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding